AI assistant
Sending…
Fulgent Genetics, Inc. — Director's Dealing 2020
Sep 24, 2020
32553_dirs_2020-09-23_90c05a3b-7905-409f-b29d-e8dcd929cacb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-09-11
Reporting Person: Xie Jian (Chief Operating Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 451295 | Direct |
Footnotes
F1: On September 14, 2020, the reporting person filed a Form 4 which inadvertently reported that, following his transfer of shares to a blind trust, he directly owned 451,736 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 451,295 shares of the issuer's common stock following such transfer.
More from Fulgent Genetics, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 26